Pharma channel feed – Endpoints News

Pharma channel feed

Mylan CEO Bresch hopes to tame the mob with a 50% discount for the EpiPen

9 years ago

AstraZeneca sells off more assets from its island of misfit drugs in $1.6B Pfizer deal

9 years ago

Clovis soars as its PARP drug rucaparib lines up for FDA review with positive data

9 years ago

Google Ventures’ Krishna Yeshwant is hunting for the next big new idea in biotech

9 years ago

Chinese development group blueprints $1B-plus biotech campus in South San Francisco

9 years ago

Portola slammed by a surprising FDA rejection for its anti-anticoagulant

9 years ago

Bind burial complete, Andrew Hirsch lands the CFO’s job at high-profile Agios

9 years ago

What's Gilead's next deal going to look like? CEO Milligan cites blockbuster filgotinib pact

9 years ago

FDA experts unanimously endorse Amgen’s biosimilar of AbbVie’s $14B franchise drug

9 years ago

Knock it off: Biosimilars are not a 'knockoff' drug

9 years ago

Why we need to lower U.S. regulatory barriers around biosimilar approvals now

9 years ago

Novartis shoots for early OK of a ‘breakthrough’ blood cancer drug after reversing organ damage in trial

9 years ago

Troubled Infinity axes 100 staffers, shutters trials and rewards top execs after AbbVie walks away from deal

9 years ago

Regulus craters after FDA slaps a hold on hep C RNA drug following 2nd case of jaundice

9 years ago

Third time the charm? Analyst says a marketing decision is “imminent” for Sarepta’s Duchenne drug eteplirsen

9 years ago

Bristol-Myers’ nivolumab grabs its sixth breakthrough designation as new links to autoimmune diseases creep up

9 years ago

Scoring the 5 top phase III drugs in the global pipeline

9 years ago

IPO bound? CRISPR Therapeutics ups B round to a cool $140M

9 years ago

Medivation to Sanofi (in translation): You don't know beans about cancer drug development(!)

9 years ago

What’s ahead for UK biotechs in the wake of Brexit? It's not a pretty picture

9 years ago

VC giant NEA backs an upstart’s plan to tackle neurodegeneration

9 years ago

Ebola! Zika! ATM! Inovio CEO Kim called out for gaming pandemic panic

9 years ago

Zombie biotech Eleven Bio sheds staff in the final wind down

9 years ago

Is Biogen the most desperate buyer scouting the biotech market?

9 years ago

First page Previous page 342 343 344345346 Next page Last page